
Early drug development: paving the way to patient-centred design
Adding precision to dose-finding in early-phase clinical trials has become critical in the immunotherapy era, and moving away from paradigms of the past has become mandatory
Adding precision to dose-finding in early-phase clinical trials has become critical in the immunotherapy era, and moving away from paradigms of the past has become mandatory
There is a broader negligence of the public health consequences of individual actions among the health providers
There is a misunderstanding in what financial conflict of interests do on single people and what system implications they may have
Having treatment protocols for the rich countries and alternative protocols for the poor ones still nurtures global health disparities
A virtual space where to reflect on sustainability in cancer care — Authored by Dario Trapani.
A virtual space where to reflect on sustainability in cancer care - Authored by Dario Trapani.
A virtual space where to reflect on sustainability in cancer care - Authored by Dario Trapani.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.